Monopar Therapeutics (NASDAQ:MNPR) reported its Q4 earnings results on Thursday, March 28, 2024 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Monopar Therapeutics beat estimated earnings by 20.0%, reporting an EPS of $-0.12 versus an estimate of $-0.15.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 11.0% drop in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Monopar Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.